Paul Tudor Jones's MAZE Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 24,059 shares of Maze Therapeutics, Inc. (MAZE) worth $996,764, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in MAZE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Maze Therapeutics (MAZE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maze Therapeutics (MAZE) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +24,059 | New Buy | 24,059 | $41.43 |
Paul Tudor Jones's Maze Therapeutics Investment FAQs
Paul Tudor Jones first purchased Maze Therapeutics, Inc. (MAZE) in Q4 2025, acquiring 24,059 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Maze Therapeutics, Inc. (MAZE) for 1 quarters since Q4 2025.
Paul Tudor Jones's largest addition to Maze Therapeutics, Inc. (MAZE) was in Q4 2025, adding 24,059 shares worth $996,764.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 24,059 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $996,764.
As of the Q4 2025 filing, Maze Therapeutics, Inc. (MAZE) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Maze Therapeutics, Inc. (MAZE) was 24,059 shares, as reported at the end of Q4 2025.